Inventor · disambiguated record
Xi Cheng
Also filed as: CHENG XI
7 granted patents·2 pending applications·3 citations·filing 2012–2021
72Inventor score
Files withJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD6CHINESE PLA GENERAL HOSPITAL1LIU YANG1SHANGHAI INST MATERIA MEDICA CAS1
Top patents by PatentIndex Score
9 records- 0175US11643405B2Compound for treatment or prevention of liver diseasesJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2019·Granted May 9, 2023·1 cites·8 claims
- 0272US10875865B2URAT1 inhibitor and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 29, 2020·1 cites·3 claims
- 0372US10399971B2Compound for treating or preventing hyperuricemia or goutJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 3, 2019·1 cites·9 claims
- 0459US8637013B2Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axisLIU YANG·Filed 2012·Granted Jan 28, 2014·0 cites·8 claims
- 0553USRE50083EURAT1 inhibitor and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 20, 2024·0 cites·20 claims
- 0648US2024041508A1Fracture repair device realizing transition from mechanical fixation (association of osteosynthesis, ao) to biological fixation (biological osteosynthesis, bo)CHINESE PLA GENERAL HOSPITAL·Filed 2021·Application pending·0 cites
- 0747US11597725B2URAT1 inhibitor for promoting uric acid excretionJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 7, 2023·0 cites·10 claims
- 0847US2023133600A1Pharmaceutical use of ketoamide-based compoundSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 0933US10005744B2Compounds for the treatment or prevention of breast cancerJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2016·Granted Jun 26, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Xi Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →